EdiGene Company
EdiGene is a clinical-stage biotechnology company focused on leveraging the cutting-edge genome editing technologies to accelerate drug discovery and develop novel therapeutics for a broad range of genetic diseases and cancer.
Headquarters:
China
Founded Date:
2015
Technology:
Rare Genetic Disorders
Estimated Revenue:
$10M to $50M
Industry:
Stem Cell Exhaustion
Funding Status:
Early Stage Venture